The purpose of our study is to investigate whether there are qualitative and quantitative imaging markers on the post reduction MR study that can predict the development of AVN using follow-up pelvic radiographs as reference standards. Post-reduction contrast-enhanced MR studies from thirty-seven infants with unilateral DDH were retrospectively reviewed which showed focally (27%) or globally decreased femoral head enhancement (22%). None of the clinical and imaging markers, including both qualitative and quantitative imaging factors present on the post reduction contrast-enhanced MR, can predict the future development of AVN, which sheds light on our incomplete understanding of the underlying pathophysiology.
Thirty-seven infants with DDH (32 girls, 5 boys; mean age at surgery: 8.2 months ± 3.4, range 3 – 18) underwent either closed (n=33; 89%) or open (n=4; 11%) hip reductions. Post reduction MR studies showed preserved enhancement in 19 hips (51%), focally decreased enhancement in 10 hips (27%) and globally decreased enhancement in 8 hips (22%). Initial follow-up radiographs (mean months from surgery: 14.8 ± 3.5, range 11-24) showed features suggestive of AVN in 17 (46%). No significant association was identified between those with features of AVN and age at surgery (p=0.33), surgical approach (p=0.68), qualitative patterns of femoral head enhancement (p = 0.97), and hip abduction angle (p = 0.47), Table 1. The enhancement ratios were not significantly different between treated hips and the contralateral untreated hips (p=0.18) and between treated hips with and without features of AVN (p=0.84), Table 2. Twenty-five (68%) patients [NJC1] [BCCA2] had additional radiographic follow-ups (mean months from surgery: 46.7 ± 24.4, range 13-92). Of the 11 patients who had initial features of AVN, only 7 (55%) had persistent features of AVN.
AVN of the femoral head is one of the most dreadful complications of treatment for DDH. Post reduction MR is becoming more routinely utilized to confirm adequate reduction and preserved femoral head perfusion. Although differences in prognosis between focal and diffusely decreased enhancement were previously demonstrated, our results failed to identify any relevant clinical or imaging markers that predict the development of AVN. This may be partially due to the fact that only 55% of abnormal hips with features of AVN on initial radiographs had persistent features at delayed radiographic follow-up, which questions diagnostic accuracy of the Salter classification to identify AVN a priori.
None of the clinical and imaging markers, including both qualitative and quantitative imaging factors present on the post reduction contrast-enhanced MR, can predict the future development of AVN, which sheds light on our incomplete understanding of the underlying pathophysiology and suggests additional undiscovered factors that influence the development of AVN.
1. Tiderius C, Jaramillo D, Connolly S, Griffey M, Rodriguez DP, Kasser JR, et al. Post-closed Reduction Perfusion Magnetic Resonance Imaging as a Predictor of Avascular Necrosis in Developmental Hip Dysplasia. J Pediatr Orthop [Internet]. 2009 Jan [cited 2018 Nov 6];29(1):14–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19098638
2. Gornitzky AL, Georgiadis AG, Seeley MA, Horn BD, Sankar WN. Does Perfusion MRI After Closed Reduction of Developmental Dysplasia of the Hip Reduce the Incidence of Avascular Necrosis? Clin Orthop Relat Res [Internet]. 2016 May 20 [cited 2018 Nov 6];474(5):1153–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26092677
Fig 2. Coronal post-contrast image from a 5 month-old girl after closed right hip reduction shows globally decreased enhancement of the right femoral head (arrow). Note the normally enhancing vascular channels within the contralateral left femoral head (arrowhead).